These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 3987730)
1. Severe respiratory infection with Branhamella catarrhalis in an African child. Bogaerts J; Lepage P; Vande Weghe JP; Vandepitte J Eur J Pediatr; 1985 Mar; 143(4):303-4. PubMed ID: 3987730 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to beta-lactamase producing strains. Nagatake T Tohoku J Exp Med; 1985 Sep; 147(1):1-13. PubMed ID: 3000026 [TBL] [Abstract][Full Text] [Related]
3. [Antibiotic sensitivity of Branhamella catarrhalis isolated from respiratory tract infections]. Nishioka K; Ida S; Takishima T Jpn J Antibiot; 1984 Jul; 37(7):1289-93. PubMed ID: 6567671 [TBL] [Abstract][Full Text] [Related]
4. Respiratory tract infections due to Branhamella catarrhalis and Neisseria species. McGowan JE Curr Clin Top Infect Dis; 1987; 8():181-203. PubMed ID: 3151758 [No Abstract] [Full Text] [Related]
5. Branhamella catarrhalis: a respiratory pathogen in children? Marriott D; Dorman DC Aust N Z J Med; 1986 Apr; 16(2):247. PubMed ID: 3463283 [No Abstract] [Full Text] [Related]
7. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis. Eliasson I; Kamme C Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190 [TBL] [Abstract][Full Text] [Related]
8. Bronchopulmonary infection due to Branhamella catarrhalis. McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451 [TBL] [Abstract][Full Text] [Related]
9. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen. Enright MC; McKenzie H J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030 [TBL] [Abstract][Full Text] [Related]
15. [Branhamella catarrhalis: its respiratory pathogenicity in childhood]. Moreno Galdo A; Ferrer Marcelles A; Aizpurúa Galdeano P; Navarro Aguirre M; Fernández Pérez F; Iglesias Berengue J An Esp Pediatr; 1990 Aug; 33(2):135-9. PubMed ID: 2125809 [TBL] [Abstract][Full Text] [Related]
16. Respiratory symptoms due to Branhamella catarrhalis and other Neisseria species infections--response to erythromycin therapy. Hamedani P; Hafiz S; Ali J; Memon R; Ali S; Ali M; Ansari M; Siddique I; Raza R Clin Ther; 1989; 11(5):633-9. PubMed ID: 2509070 [TBL] [Abstract][Full Text] [Related]
17. Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis. Percival A; Corkill JE; Rowlands J; Sykes RB Lancet; 1977 Dec; 2(8049):1175. PubMed ID: 73082 [No Abstract] [Full Text] [Related]
18. Branhamella catarrhalis respiratory infections in The Netherlands. Maesen FP; Davies BI Drugs; 1986; 31 Suppl 3():83-6. PubMed ID: 3732084 [TBL] [Abstract][Full Text] [Related]
19. Moraxella catarrhalis, a human respiratory tract pathogen. Murphy TF; Parameswaran GI Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579 [TBL] [Abstract][Full Text] [Related]
20. Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response. McLeod DT; Ahmad F; Croughan MJ; Calder MA Drugs; 1986; 31 Suppl 3():109-12. PubMed ID: 3732080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]